INTRODUCTION
Degradation and remodeling of the extracellular matrix is associated with many normal biological events, including wound repair, tissue involution, and cell migration, as well as with various disease processes, such as arthritis, ulceration, and tumor metastasis (Werb, 1989; Matrisian et al., 1991; Parks and Sires, tPresent address: Department of Dermatology, LFI-Gebaeude 5/201, University of Cologne, Joseph-Stelzmann Strasse 9, D-50924 Cologne, Germany. § Corresponding author: Division of Dermatology, Jewish Hospital, 216 South Kingshighway, St. Louis, MO 63110. 1996) . Matrix metalloproteinases (MMPs) constitute a subfamily of metalloenzymes with the collective potential of degrading essentially all structural components in the extracellular environment. The MMPs with known matrix-degrading ability include three collagenases, two gelatinases, two stromelysins, a metalloelastase, matrilysin, and membrane-type matrix metalloproteinase 1 (Birkedal-Hansen et al., 1993; Pei and Weiss, 1996) . Because matrix remodeling needs to be accurately controlled both spatially and temporally, the expression and activity of MMPs is highly regulated, with essentially no basal production of most proteinases in intact tissues. [The constitutive expres-sion of matrilysin by epithelium is a notable exception (Saarialho-Kere et al., 1995; Wilson et al., 1995) .] Thus, agents and processes associated with tissue remodeling, particularly cytokines and altered cell-matrix and cell-cell interactions, modulate MMP production.
Collagenase 1, along with the other two metallocollagenases, can cleave fibrillar collagens (types I, II, and III) within their triple helical domain at a neutral pH. Because type I collagen is the most abundant protein in the body, collagenases serve an essential role in initiating efficient matrix turnover. We reported that collagenase 1 is prominently, invariably, and selectively expressed by migrating basal keratinocytes involved in reepithelialization in human cutaneous wounds (Saarialho-Kere et al., 1992 , 1993a Parks, 1995) . Furthermore, collagenase 1-positive cells are not associated with an intact basement membrane but rather are migrating over the dermal and provisional matrices. These findings indicate that the new cellmatrix interactions which are established as keratinocytes migrate from their basement membrane onto the dermal matrix are critical determinants in regulating collagenase 1 expression. Indeed, we demonstrated that collagenase 1 transcription and secretion are induced in primary human keratinocytes upon contact with native type I collagen but not in cells grown on a mixture of basement membrane components (Saarialho-Kere et al., 1993a; Sudbeck et al., 1994) . As reepithelialization proceeds, active expression of collagenase 1, as determined by in situ hybridization for its mRNA, is rapidly shutoff in basal keratinocytes in contact with the restored basement membrane, although staining for the protein remains evident in some suprabasal cells (Saarialho-Kere et al., 1993a; Inoue et al., 1995) . Thus, in addition to regulation of gene expression by cell-matrix interactions, the release or activation of collagenase 1 protein may be regulated by other mechanisms in newly healed areas.
During epidermal differentiation, keratinocytes move from a low calcium environment to layers containing progressively higher concentrations of calcium (Malmqvist et al., 1984; Menon et al., 1985) . This spatial change in ion levels is associated with irreversible changes in cell phenotype characterized by alterations in cytokeratin expression, growth arrest, and cornification (Fuchs, 1990) . Cell culture studies have demonstrated that keratinocyte differentiation can be induced by raising extracellular calcium levels (Yuspa et al., 1989) and that the intracellular concentration of calcium ions increases concomitantly with keratinocyte differentiation (Sharpe et al., 1993) . Thus, because a natural calcium gradient may regulate the growth and phenotype of keratinocytes during differentiation in intact skin, a similar change in the extracellular microenvironment may influence cell behavior during epidermal wound repair.
In response to wounding, basal keratinocytes begin to migrate and acquire many characteristics associated with cell movement, such as changes in cytoskeleton structure (Kubler and Watt, 1993) and in the expression of new integrins (Hertle et al., 1992; Juhasz et al., 1993) and proteinases (Mignatti et al., 1996) . During reepithelialization, keratinocytes migrate through a low calcium environment and, as healing nears completion, enter a progressively higher calcium environment (Grzesiak and Pierschbacher, 1995) . Because collagenase 1 is selectively expressed and released by basal keratinocytes during periods of active reepithelialization, we assessed if modulation of intracellular calcium stores influence keratinocyte collagenase 1 production. In this study, we show that mobilization of intracellular calcium stores inhibits keratinocyte collagenase 1 secretion without affecting collagenase 1 mRNA levels. This mechanism may be important in blocking the unwanted release of proteinase at the cessation of epidermal repair.
MATERIALS AND METHODS Cell Culture
Primary keratinocytes were isolated from full-thickness skin obtained from reductive mammoplasty or lateral abdominoplasty and were grown under high Ca2+ conditions as described (Pentland and Needleman, 1986 ). Briefly, s.c. fat and deep dermis were removed, and the remaining tissue was incubated in 0.25% trypsin in phosphate-buffered saline for 16 h. The epidermis was then removed from the dermis, and keratinocytes were suspended in DMEM supplemented with 5% fetal calf serum, 1% HEPES, and penicillin/ streptomycin. This cell suspension was then plated in 1.75-cm2 tissue culture dishes coated with a 1 mg/ml solution of monomeric native-type I collagen (Vitrogen, Collagen Corp., Palo Alto, CA), and the adherent cells were grown for 3 to 5 d when they were about 70% confluent. A23187, thapsigargin (Calbiochem, San Diego, CA), and phorbol 12-myristate 13-acetate (PMA, Sigma Chemical Co., St. Louis, MO) were dissolved in dimethyl sulfoxide. Control cultures received an equal concentration (0.2%) of solvent. In some experiments, keratinocytes were treated with 5 x 10-' M PMA. All experiments were done with freshly isolated keratinocytes.
The human keratinocyte cell line HaCaT (Boukamp et al., 1988 ) and adult human fibroblasts isolated from healthy skin were grown to confluence in DMEM containing 10% fetal calf serum, 1% HEPES, and penicillin/streptomycin. As a positive inducer of collagenase 1 production, HaCaT cultures were stimulated with 30 ng/ml epidermal growth factor (Sudbeck et al., 1994) , and 1905 fibroblasts were stimulated with 10-8 M PMA.
In Situ Hybridization
Primary keratinocytes were plated on collagen-coated Lab-Tek chamber slides (Nunc, Naperville, IL) and processed for in situ hybridization as described (Prosser et al., 1989; Saarialho-Kere et al., 1993b) . Briefly, control and 24-h PMA-treated cells were fixed for 15 min in buffered formalin and processed for in situ hybridization as described in detail (Prosser et al., 1989) , except that proteinase K pretreatment was omitted. Cells were hybridized with 2.5 x 104 cpm/ixl of 35S-labeled antisense RNA overnight at 57°C. Samples of pyogenic granuloma (n = 12) were obtained from Dr. Neil Penneys (St. Louis University, St. Louis, MO), and 5-gm sections were hybridized for collagenase 1 mRNA (Saarialho-Kere et al., 1992) . After hybridization, slides were washed under stringent conditions, inMolecular Biology of the Cell Regulation of Collagenase in Keratinocytes cluding treatment with RNase A, and were processed for autoradiography. After development of the photographic emulsion, slides were stained with hematoxylin-eosin. Parallel controls were processed with 35S-labeled sense RNA. The specificity of the antisense RNA probe for collagenase 1 and the complete lack of reactivity with the sense probe have been demonstrated in previous studies (Saarialho-Kere et al., 1992 , 1993a .
Zymography
Gelatin and casein zymography were performed as described (Herron et al., 1986) . Serum-free conditioned medium samples were collected, and total cellular protein content was determined with the bicinchoninic acid microassay (Pierce, Rockford, IL) using bovine serum albumin as a standard. Medium samples, equivalent to 150 jig of protein, were resolved at 4°C through 10% nonreducing SDS-polyacrylamide gels impregnated with 1 mg/ml gelatin or casein. Gels were washed twice in 2.5% Triton X-100 and once in 50 mM Tris (pH 7.5) containing 10 mM CaCl2 and 1 nM ZnCl2, and were then incubated overnight at 37°C in the same buffer. Gelatinolytic and caseinolytic proteins were identified as clear bands on a dark background after staining with 1 % Coomassie blue. In parallel gels, 25 mM EDTA or 1 mM phenylmethylsulfonyl fluoride (PMSF, Sigma) were added during the zymogram incubation to verify the presence of metalloproteinase activity. Molecular weight standards (Pharmacia, Uppsala, Sweden) were used to estimate the weight of protein samples.
Immunoassays
Collagenase 1 protein was quantified using a competitive enzymelinked immunosorbent assay (ELISA; Saarialho-Kere et al., 1993b) . This assay has nanogram sensitivity, is specific for human collagenase 1, and measures total enzyme present whether free or bound to inhibitor or substrate or whether in an inactive or active form. Other than dilution, media samples were assayed without modification. Standard curves using purified human collagenase 1 were included in each assay. Results were normalized to total cellular protein.
Total Protein Synthesis Keratinocytes were treated with 0.1-5 AM A23187 or vehicle for 24 h in standard culture medium. Cultures were then incubated for 1 h in leucine-free medium to deplete the intracellular pool of leucine and were then pulsed for 3 h in leucine-free medium containing 1 ,uCi/ml [L-3H]leucine (42 Ci/mmol). The medium and cell layer were collected, and macromolecules were precipitated with trichloroacetic acid and processed for scintillation spectrophotometry as described (Sudbeck et al., 1994 (Parks et al., 1988) . Probes were prepared by labeling cDNAs for human collagenase 1, human 92-kDa gelatinase, human keratin 14, or glyceraldehyde -3-phosphate dehydrogenase (GAPDH) with [a-32P] dCTP by random priming. Collagenase 1 mRNA was also detected using a reverse transcription-polymerase chain reaction (RT-PCR) assay modified from an established quantitative procedure (Swee et al., 1995) . To remove any contaminating DNA, total RNA was treated with RQ1 RNase-free DNase and RNasin (both from Promega, Madison, WI) as described (Swee et al., 1995) . DNase-treated RNA (10 ng) was reverse transcribed with random hexamers using kit reagents and under the manufacturer's recommended conditions (GeneAmp RNA PCR kit, Perkin ElmerCetus, Norwalk, CT). For each sample, a parallel reaction was run with no reverse transcriptase. The 3' antisense primer was complementary to bases 1496-1518 in the 3' untranslated region (5'-GGACTCACACCATGTGTlTTTCC-3'), and the 5' sense primer was defined by bases 1114-1135 of the hemopexin-like domain (5'-GGGCTGTTCAGGGACAGAATGT-3'). These primers are to adjacent exons, and thus, the 405-bp DNA produced from collagenase 1 mRNA would be easily distinguished from products amplified from contaminating DNA. In addition, the resultant cDNA contains a single BamHI restriction site, which, along with microsequencing, was used to verify product identity. PCR was done for 21 cycles, and the resultant products were detected by Southern blot hybridization using a 2P-labeled collagenase 1 cDNA. RT-PCR for GAPDH mRNA was done as described (Swee et al., 1995) .
Immunoblotting
After exposure to 1 ,uM A23187 and/or 10-8 M PMA, keratinocytes were scraped and boiled in 500 ,ul of denaturing electrophoresis sample buffer. Equal aliquots (25 p.l) were resolved through 10% SDS-polyacrylamide gels and were transferred to an Immobilon-P membrane (polyvinylidene difluoride, Millipore, Bedford, MA). Blots were stained with anticytokeratin 14 as described (Busiek et al., 1995) , and bound secondary antibodies were detected by enhanced F (Amersham, Buckinghamshire, England).
Immunohistochemistry
Antibodies against cytokeratins 10 and 14 were purchased from Sigma. Deparaffinized 5-,um sections of pyogenic granuloma were processed for immunohistochemistry as described (Saarialho-Kere et al., 1993a). Endogenous peroxidase activity was blocked by incubation in 0.3% H202 for 30 min at room temperature. Antibodies were diluted 1:100, and bound antibody was detected using 3,3'-diaminobenzidine and a Vectastain ABC Elite kit (Vector Laboratories, Inc., Burlingame, CA) following the manufacturer's instructions. Sections were counterstained with Harris hematoxylin. For negative controls, we processed serial sections with nonimmune serum at a comparable dilution.
RESULTS
In Vitro Pattern of Collagenase 1 Expression To determine whether our keratinocyte culture model reflects the spatially confined expression of collagenase 1 to migrating keratinocytes as seen in actual Vol. 8, May 1997 B.D. Sudbeck et al. Figure 1 . Collagenase 1 is expressed by migrating keratinocytes in culture. Primary human keratinocytes were plated on type I collagencoated glass slides, and one-half of the cultures were treated with 5 x 10-M PMA. Twenty-four hours later, the slides were processed for in situ hybridization as described in MATERIALS AND METHODS. As seen in these dark-field photomicrographs, primary keratinocytes grown in high-calcium medium form foci (F) of differentiating cells which are surrounded by a monolayer of hyperproliferative cells wounds, we used in situ hybridization to assess which cells express collagenase 1. Similar to wounded epidermis, cultured keratinocytes grown under high calcium (1.8 mM) conditions form subpopulations of migrating, proliferating, and differentiating cells (Hennings et al., 1980; Pentland and Needleman, 1986) . Differentiating keratinocytes are seen as blurred foci and are surrounded by a monolayer apron of hyperproliferative cells. Bordering the hyperproliferative cells, and often detached from them, are migrating keratinocytes (Figure 1 , arrows). Reflecting the phenotype of basal cells involved in reepithelialization in vivo, collagenase 1 mRNA was detected only in keratinocytes migrating from the colonies of proliferating and differentiating cells (Figure 1 , arrows). Treatment with PMA, a potent stimulator of MMP production in keratinocytes (Sudbeck et al., 1994) , markedly increased collagenase 1 expression. Paralleling the pattern seen in non-PMA-treated cells, signal for collagenase 1 mRNA was seen only in migrating keratinocytes ( Figure 1 ). The morphology and organization of PMA-treated cultures was not different from those features of keratinocytes on collagen alone, except that the differentiating foci were more dense ( Figure 1 ). Thus, our primary human keratinocyte model duplicates the restricted expression of collagenase 1 to migrating basal keratinocytes as seen in vivo. These observations also indicate that PMA can be used to enhance collagenase 1 expression, and hence, its detectability, without affecting its limited production by a functionally defined subpopulations of keratinocytes.
A23187 Inhibits Keratinocyte Collagenase 1 Accumulation
To determine the effect of increased intracellular Ca21 levels on MMP production by keratinocytes, primary human cells were treated with 1 ,tM A23187. (Primary keratinocytes grown in high calcium medium do not attach to tissue culture plastic and, hence, require an exogenous substratum.) After 16 h, conditioned medium was collected and analyzed by zymography to assess proteinase secretion. A number of proteolytic bands were detected by gelatin zymography in control medium (Figure 2 ), and these likely represent 92-kDa progelatinase, its activated form at about 82-kDa, 72- Figure 1 (cont). (Pentland and Needleman, 1986) kDa progelatinase, and procollagenase 1, which resolves as a doublet at 55-57 kDa. The collagenase 1 bands were also detected by casein zymography, which is a much less sensitive assay than gelatin zymography but more selective for collagenase activity. Gelatinase levels were greatly reduced, and collagenase 1 was eliminated in medium from keratinocytes treated with A23187 ( Figure 2 ). In both gel systems, all proteolytic activity was inhibited by EDTA but not by PMSF, a serine proteinase inhibitor, indicating that the bands detected were MMPs. To better define the effect of A23187 on keratinocyte MMP production, we quantified the accumulation of collagenase 1 protein in the medium in response to various doses of this ionophore. A23187 mediated a dose-dependent decrease in collagenase 1 accumulation, and at 5 ,uM, secreted enzyme was not detected (Figure 3 ). PMA stimulated collagen-mediated collagenase 1 production about 10-fold, but these enhanced levels were markedly reduced by A23187 (Figure 3 ). To determine whether inhibition of collagenase 1 accumulation was specific to A23187, we tested another calcium ionophore. Thapsigargin, which increases intracellular calcium levels by specifically inhibiting endoplasmic reticulum Ca2+-ATPase (Takemura et al., 1989; Thastrup et al., 1990) , markedly reduced the release of collagenase 1 from control keratinocytes but had only a minor inhibitory effect on PMA-stimulated cells (Figure 3 ). This weak inhibition in PMA-treated keratinocytes suggests that thapsigargin and A23187 block collagenase 1 accumulation by distinct mechanisms. In agreement with gelatin zymography (Figure  2 ), A23187 reduced secreted levels of 92-kDa gelati- (Figure 4) . Thus, these data indicate that calcium mobilization is involved in the regulation of MMP production by keratinocytes. Because fluctuations of intracellular Ca2+ levels influence numerous cellular events, we measured total protein synthesis to determine whether the production and release of new proteins was modulated by A23187. With ionophore concentrations of .1 ,uM, cell-associated radioactivity was not significantly affected, but secreted radiolabeled protein, which accounted for about 3% of total radioactivity, was reduced to about 60% of control levels ( Figure 5 , HaCaT). A23187 increased collagenase 1 production in synovial and dermal fibroblasts (Unemori and Werb, 1988; Lohi et al., 1994) . In our studies, however, A23187 did not affect the low basal secretion of collagenase 1 by human skin fibroblasts ( Figure 5 , HSFb). In addition, PMA-stimulated levels of collagenase 1 in fibroblasts were not significantly affected with low does of the ionophore but were slightly increased with 1 ,.M A23187 (Figure 5 , HSFb). These data indicate that cell-specific mechanisms regulate collagenase 1 expression in keratinocytes.
A23187 Does Not Inhibit Collagenase 1 mRNA Accumulation In most experimental models, the concentration of secreted collagenase 1 correlates with the steady-state levels of its mRNA, but posttranscriptional mechanisms can also contribute to the regulation of enzyme expression (Delany and Brinckerhoff, 1992; Vincenti et al., 1994) . To determine the mechanism controlling Figure 6 ). However, because only a subset of keratinocytes, namely, the migrating cells, express collagenase 1 in response to collagen ( Figure  1 ), its mRNA would be markedly diluted in extracts of total RNA. Collagenase 1 mRNA was detected by RT-PCR, and the relative levels were not affected by increasing concentrations of A23187 ( Figure 6 ). In agreement with the ELISA (Figure 3 ) and in situ hybridization ( Figure 1 ) data, PMA markedly increased collagenase 1 mRNA levels ( Figure 6 ). Cotreatment with A23187, however, did not affect the PMA-mediated stimulation of collagenase 1 mRNA levels ( Figure  5 ), even though the ionophore significantly reduced secreted protein levels (Figures 2 and 3 ). These data suggest that A23187 inhibits accumulation of collagenase 1 in both control and PMA-stimulated keratinocytes by a posttranscriptional mechanism. Unlike collagenase 1, levels of 92-kDa gelatinase mRNA in PMA-stimulated keratinocytes dropped about threefold to fivefold in response to A23187 (Figure 6 ), similar in magnitude to the drop in secreted protein levels (Figure 4 ). These data indicate that A23187 regulates production of different MMPs in keratinocytes by distinct mechanisms. Figure 7A ). Reflecting the ELISA results (Figure 3 ), cotreatment with A23187 inhibited collagenase 1 accumulation in the medium; however, A23187 led to an accumulation of intracellular collagenase 1 ( Figure 7A ). In agreement with our Northern blot data (Figure 6 ), the sum of the densitometric values for the immunoprecipitated bands of the medium and cell layer indicated that nearly equivalent levels of collagenase 1 were produced in PMA-treated cultures with or without A23187 ( Figure 7A ). The principle quantitative difference was the distribution of the protein in response to ionophore, suggesting that modulation of intracellular calcium stores regulate collagenase 1 secretion and not translation. In another experiment, A23187 mediated a dose-dependent and marked sequestration of intracellular collagenase 1 in basal (i.e., not PMA-treated) keratinocytes ( Figure 7B ). Procollagenase 1 typically resolves as a doublet protein of 54 and 52 kDa, separated by approximately 2 kDa, due to differences in glycosylation of the precursor protein.
In both experiments, we detected no difference in the migration and pattern of immunoprecipitated procollagenase 1 (Figure 7 ), suggesting that A23187 treatment did not influence posttranslational modification of the enzyme and that the block in secretion occurred distal to the Golgi apparatus. Alteration of intracellular calcium levels can hinder protein secretion by affecting protein folding (Lodish and Kong, 1990; Suzuki et al., 1991) . To determine whether treatment with A23187 affected the procollagenase 1 structure, we assessed the ability of the proenzyme to cleave itself upon activation with APMA. Treatment with this organomercurial disrupts a conserved cys-his bond which maintains the enzyme in an inactive state. Upon disruption of this bond, the catalytic domain becomes active and cleaves the N- terminal prodomain, reducing the mass of the enzyme by about 10 kDa. With the addition of APMA, both secreted and cell-associated procollagenase 1, whether from control or A23187-treated keratinocytes, was converted to the lower molecular weight, active form of the enzyme ( Figure 7B ). The higher molecular weight bands seen above procollagenase 1 in the APMA-treated samples likely represent complexes that form with activated MMPs (Goldberg et al., 1992) . The ability of procollagenase 1 to be activated and to cleave itself indicates that A23187 did not cause a change in enzyme conformation.
A23187 Inhibition of Collagenase 1 Accumulation Is Reversible One explanation for the ionophore effect on collagenase 1 secretion is that as the keratinocytes differentiate and become cornified, they create a physical barrier to secretion. Cornification is irreversible, and cells stimulated to differentiate develop a cornified envelope within a short period of time (Hennings et al., 1980) . To assess whether cornification impedes collagenase 1 accumulation, cells were treated with 1 ,uM A23187, and 12 h later, one-half of the cultures were washed and incubated in ionophore-free medium for 4 h more. Again, PMA stimulation caused an increase in collagenase 1 accumulation that was blocked by cotreatment with A23187 ( Figure 8 ). However, the ability to secrete collagenase 1 was restored in cultures that were washed and subsequently incubated in A23187-free medium (Figure 8 ). These results indicate that the effect of A23187 on the ability of keratinocytes to secrete collagenase 1 is reversible upon removal of the ionophore.
Keratinocyte Differentiation During wound healing in vivo, collagenase 1 is produced only by basal keratinocytes; enzyme expression is not detected in suprabasal cells (Saarialho-Kere et al., 1993a) . To determine whether inhibition of collagenase 1 secretion by A23187 correlated with a change in keratinocyte differentiation, we assessed the expression of keratin 14, which is selectively expressed by basal keratinocytes in intact skin. Treatment with A23187 alone did not significantly affect the level of keratin 14 mRNA or protein in control cells (Figure 6 ). PMA treatment decreased the expression of keratin 14 mRNA (Figure 6 ), consistent with its differentiationinducing effects (Hawley-Nelson et al., 1982) , and cotreatment with ionophore caused a further decrease in keratin 14 mRNA ( Figure 6 ). The PMA-mediated decrease in keratin 14 protein was accompanied by a slight decrease in protein levels over the 18-h treatment period ( Figure 6 , Western blot). Because PMA decreased keratin 14 expression while inducing collagenase 1 accumulation, these results suggest that the Regulation of Collagenase in Keratinocytes Figure 7 . A23187 inhibits secretion of collagenase 1 from keratinocytes. (A) Primary keratinocytes were treated for 4 h with 1 ,uM A23187, 5 x 10-9 M PMA, or with both compounds, and were then washed with methionine-free medium. Proteins were radiolabeled by pulsing with 50 ,uCi/ ml [L-35SJmethionine in methionine-free DMEM plus additives. After 4 h, the conditioned medium and monolayers were processed for collagenase 1 immunoprecipitation. Radiolabeled proteins were detected by fluorography and were quantified by laser densitometry and expressed as arbitrary units. The duplicate lanes represent data from keratinocytes derived from two separate patients. (B) Keratinocytes from another donor were treated with 1 or 10 ,uM A23187 (but no PMA) and metabolically labeled as described above. Before immunoprecipitation, conditioned medium and cell extracts were treated with APMA for 1 h at 37°C. effect of the ionophore on collagenase 1 secretion is not strictly due to cellular differentiation. To assess the in vivo correlation between collagenase 1 expression and basal cell markers, we stained sections of pyogenic granulomas with antibodies for keratin 14 (basal cells) and keratin 10 (suprabasal cells). Pyogenic granulomas are small, highly vascular lesions with many small ulcerations of the epidermis. As we have reported, pyogenic granulomas display many of the epidermal features seen in acute wounds (Saarialho-Kere et al., 1992 , 1993a . In intact skin, keratin 14 was detected only in basal keratinocytes, and keratin 10 was seen in suprabasal cells (Figure 9 , top panels). At the wound edge, however, staining for keratin 10 was not detected at the migrating front of the epidermis, even though stratification was evident in this area (Figure 9 , middle panels). In contrast, all keratinocytes, whether basal or suprabasal, stained for keratin 14 at the ulcer edge ( Figure 9 , middle panels). No signal was seen in sections incubated in nonimmune serum. Collagenase 1-expressing keratinocytes were confined to the basal layer at the migrating front and were not seen in any suprabasal layer (Figure 9 , bottom panels). These findings, which were consistently seen in 12 specimens, suggest that the migrating front of epidermis is made of keratinocytes with a basal or hyperproliferative phenotype.
DISCUSSION
In the intact epidermis, keratinocytes maintain a natural calcium gradient, with the basal proliferative cells in a low calcium environment and suprabasal cells in a gradually increasing higher calcium environment (Malmqvist et al., 1984; Menon et al., 1985) . Apparently, external calcium plays a role in the development and maintenance of a healthy epithelium. Following wounding and during reepithelialization, distortion of the normal calcium gradient may modify the local environment of the basal keratinocyte and modulate cell phenotype (Grzesiak and Pierschbacher, 1995) . Soon after injury, basal keratinocytes at the wound margin change their morphology and behavior from that of a progenitor cell to one appropriate for their new role as a migratory cell. Our in vivo studies on a variety of chronic and normally healing wounds indicate that collagenase 1 is always expressed by migrating basal keratinocytes at the wound edge (SaarialhoKere et al., 1992 (SaarialhoKere et al., , 1993a (SaarialhoKere et al., , 1994 . The invariant expression of collagenase 1 in wounded skin indicates that this enzyme serves a critical role in epidermal repair. Indeed, as we recently reported (Pilcher et al., 1997) , the catalytic activity of collagenase 1 is required for the migration of keratinocytes over a collagen matrix.
At the onset and during epidermal migration, keratinocytes contact extracellular matrix components of the dermal and provisional matrices, and these altered cell-matrix interactions may provide early and sustained signals informing keratinocytes that they are in an injured environment. In addition, expression of collagenase 1 mRNA is rapidly shutoff once reepithelialization is completed and the basement is restored (Saarialho-Kere et al., 1993a; Inoue et al., 1995) . Although a compelling argument can be made for the role of cell-matrix interactions in initiating collagenase 1 expression and activating basal keratinocytes in Vol. 8, May 1997 819 VW.0 B.D. Sudbeck et al. wounds, other factors likely contribute to regulating proteinase production. For example, collagenase 1 is overexpressed in chronic ulcers compared with acute wounds (Sank et al., 1989; Saarialho-Kere et al., 1993a) . Because cell-matrix interactions are likely similar in healing and nonhealing lesions, excess production of collagenase 1 may be stimulated by soluble factors in the wound environment. In addition, our in vitro data demonstrate that only migrating keratinocytes express collagenase 1, although all cells are grown on collagen (Figure 1) . Thus, other factors, such as cell-cell contacts and differentiation-associated processes, may also regulate enzyme production and activity.
Our results demonstrate that ionophore-mediated mobilization of intracellular calcium stores blocked secretion of collagenase 1 by keratinocytes without affecting the steady-state levels of its mRNA. Furthermore, chloramphenicol acetyltransferase transcription under control of a 2.2-kb fragment of human collagenase 1 promoter was not affected by ionophore treatment (data not shown but provided to reviewers), indicating that collagenase 1 gene transcription was not altered by modulation of intracellular calcium levels. Previously, we demonstrated that expression from this construct parallels modulation of endogenous collagenase 1 production in keratinocytes (Sudbeck et al., 1994) . In contrast to keratinocytes, calcium ionophores stimulate collagenase-expression by fibroblasts (Unemori and Werb, 1988) , although our data showed only a minimal, if any increase ( Figure 5 ). Thus, inhibition of enzyme secretion by increased intracellular calcium concentration appears to be a keratinocyte- specific mechanism to control collagenase 1 activity. Analogously, transforming growth factor-X31 represses collagenase 1 expression in fibroblasts but stimulates production in keratinocytes (Mauviel et al., 1996) , indicating further that this metalloproteinase is regulated by cell-type-specific mechanisms. In contrast, A23187 inhibits expression of the 92-kDa gelatinase enzyme by keratinocytes (Figures 2 and 4) and fibrosarcoma cells (Lohi and Keski-Oja, 1995) . Thus, our findings support the idea that different MMPs are regulated differently in different cell types.
In agreement with earlier findings (Kallioinen et al., 1995) , all keratinocytes of the migrating front of epidermis stained for keratin 14, a basal cell marker, but none stained with antibody for keratin 10, a suprabasal-specific protein (Figure 9 ). Because suprabasal cells at the migrating front do not express collagenase 1 mRNA, these in vivo observations support the idea that induction and maintenance of gene expression of this metalloproteinase is regulated more by the location of the producing cell rather than its state of differentiation. As stated, interaction with type I collagen induces collagenase 1 gene expression in keratinocytes (Sudbeck et al., 1994) , and loss of contact with the matrix may down-regulate transcription without concomitantly reducing mRNA stability or inhibiting enzyme translation. Indeed, we have observed collagenase 1 protein in suprabasal cells in many wounds (Saarialho-Kere et al., 1993a) . If secreted and activated, collagenase 1 may degrade potential substrates in the epidermis. Although fibrillar collagens are the preferred substrates for collagenase 1, the enzyme can degrade other molecules, such as proteoglycans and serpins (Desrochers et al., 1991; Halpert et al., 1996) . Extracellular inhibitors are probably not plentiful in the extracellular space surrounding suprabasal keratinocytes. For example, tissue inhibitor of metalloproteinase 1 is expressed by basal keratinocytes in wounded skin but only transiently during the initial phase of reepithelialization (Stricklin et al., 1993) . Thus, blocking secretion of collagenase 1 from keratinocytes may provide an important mechanism to rapidly decrease the release of this enzyme which is no longer needed once reepithelialization is completed and stratification resumes.
Modulation of calcium levels may provide a means to block secretion of more than just collagenase 1. After all, secretion of many cell products is affected by calcium concentration, and indeed, the slight decrease we detected in soluble radioactive protein (Table 1) suggests that secretion of proteins, in addition to collagenase 1, was also inhibited by A23187. Inhibition of the secretion of multiple proteins, however, does not diminish the relevance of our findings. Although collagenase 1 production and release are reliable markers of activated basal keratinocytes, these cells make other proteins as well, such as integrins, basement mem-K14 K14.
. .
-. Figure 9 . Keratin expression in the migrating front of keratinocytes in wounds. Sections of pyogenic granuloma (n = 12) were stained with antibodies for keratin 14 (K14) or keratin 10 (K10). The top micrographs show an area of intact skin within the pyogenic granuloma biopsy and the predictable presence of keratin 14 in the basal layer of the epidermis and keratin 10 in the suprabasal layers. Bar, 100 ,um for top panels. In the middle micrographs, an ulceration is seen (U) bordered by two migrating tongues of epidermis (arrows). The inset shows a higher magnification of the forward extent of the horizontal migrating front. At the wound edge, staining for keratin 14 was seen in both basal and suprabasal keratinocytes, but keratin 10 was not detected. Bars, 240 ,um for middle panels and 50 ,um for insets, respectively. The bottom panels show dark-field and bright-field illuminated views of a section hybridized for collagenase 1 mRNA. Autoradiographic signal is seen only in basal keratinocytes (arrows) at the ulcer edge and not in any suprabasal cell. The upper extent of the epidermis is marked by arrowheads. Autoradiographic exposure was for 14 d. Bar, 50 ,um for bottom panels.
brane proteins, cytokines, and other proteinases (R0omer et al., 1991; Saarialho-Kere et al., 1993a Fini et al., 1996) . Modulation of calcium levels may contribute to regulating the site-specific expression of many, if not all, of these markers. Depletion of calcium from the endoplasmic reticulum can inhibit protein secretion by affecting protein folding (Lodish and Kong, 1990; Suzuki et al., 1991 ), but we do not believe that a change in enzyme conformation contributed to the inefficient release of collagenase 1 from keratinocytes exposed to A23187. Collagenase 1, as for all MMPs, has an N-terminal prodomain of 8 kDa that is responsible for maintaining the enzyme in an inactive or zymogen state, a catalytic domain of about 21 kDa that binds the active site Zn2+, and other domains that contribute to defining substrate specificity. The zinc-coordinating region contains three conserved histidine residues which represent three of four zinc-interactive ligands (Goldberg et al., 1986) . The propeptide is characterized by the invariant sequence PRCGVPD, with the cysteine residue representing the fourth interactive ligand of the active site Zn2+. Enzyme latency is conferred by this Cys-Zn interaction (Van Wart and Birkedal-Hansen, 1990) . For MMP zymogens to be activated, the Cys-Zn association must be disrupted, which is thought to occur in vivo by cleavage of the prodomain by another protease. However, any mechanism that disrupts this bond, including nonproteolytic processes, such as treatment with chaotropes, sulfhydryl chelators, and reactive oxygen species, leads to enzyme activation. Importantly, and relevant to our article, once the Cys-Zn interaction is disrupted, procollagenase will cleave its N-terminal prodomain, producing a protein that resolves in a polyacrylamide gel about 10 kDa smaller than the zymogen. Our data in Figure 7B show that in response to APMA intracellular and secreted procollagenase 1, in both control and A23187-treated keratinocytes, was converted to the active form of the enzyme. Because improper folding would likely hinder autoactivation, which requires the proper function of the zinc-binding and more C-terminal domains, we conclude that inhibition of collagenase 1 secretion by calcium ionophore is not caused by improper protein folding.
All metalloproteinases have two conserved calciumbinding domains located near the zinc-binding domain (Birkedal-Hansen et al., 1993) . Thus, if altered calcium levels caused misfolding of procollagenase 1 and, in turn, hindered secretion of the enzyme, then release of the 92-kDa gelatinase, which shares high homology in these critical areas, would likely be similarly affected. Our data, however, suggest that A23187-mediated down-regulation of 92-kDa gelatinase mRNA levels and did not affect secretion of this enzyme. Furthermore, because calcium ionophores stimulate collagenase 1 expression by fibroblasts with a concomitant increase in soluble enzyme levels (Unemori and Werb, 1988) , the block in collagenase 1 secretion from keratinocytes is seemingly a cell-specific response to modulation of intracellular stores and is not a common effect of treatment with ionophores.
The potential importance of this proposed mechanism is highlighted by observations in transgenic mice which demonstrated that forced expression of collagenase 1 in suprabasal keratinocytes leads to severe epidermal defects such as markedly thickened living skin (acanthosis) and cornified layers (hyperkeratosis; D'Armiento et al., 1995) . Similarly, functional expression of other basal cell-specific proteins can cause epidermal anomalies. At the completion of reepithelialization, integrins which are normally confined to the basal keratinocytes are seen for a few days posthealing in the newly formed suprabasal cells (Hertle et al., 1992; Juhasz et al., 1993) . Similar to what we propose here for preventing collagenase 1 secretion, posttranscriptional mechanisms inhibit the transport of these matrix receptors to the surface of suprabasal cells (Hotchin and Watt, 1992) . However, expression of functional integrins by suprabasal cells in transgenic mice causes hyperproliferative anomalies resembling psoriasis (Carroll et al., 1995) . In addition, overexpression of keratin 16, which is normally expressed by postmitotic cells at the wound edge, causes acanthosis and hyperkeratosis (Takahashi et al., 1994) . Thus, altered calcium levels may provide a mechanism to prevent the potentially deleterious secretion of collagenase 1, as well as production or activity of other basal cell proteins, by keratinocytes which have moved away from the stratum basalis.
